In line with these observations, a significantly higher percentage of CLL cells in the NFAT2-deficient cohort were in the G2/M and S phases of the cell cycle documenting increased aggressiveness of disease (Fig. 2f). The gene discussed is NFATC1; the disease is B-cell chronic lymphocytic leukemia.